CordovaCann (LVRLF) FCF Margin (2018 - 2019)

CordovaCann (LVRLF) recorded quarterly FCF Margin of 4890.79% in Q2 2019, up 209.0% quarter-over-quarter from 4486.9% in Q1 2019.

CordovaCann (LVRLF) FCF Margin (2018 - 2019) Analysis & Trends

CordovaCann's FCF Margin history runs 2 years deep, the most recent figure standing at 4890.79% for Q2 2019.

In Q2 2019, FCF Margin changed N/A year-over-year to 4890.79%; the TTM figure through Jun 2019 stood at 903332.26% (changed N/A YoY), while the FY2025 annual figure was 7.88%, down 294.0% from the prior year.
FCF Margin was 4890.79% for Q2 2019 at CordovaCann, up from 4486.9% in the prior quarter.
In the past five years, FCF Margin ranged from a high of 4890.79% in Q2 2019 to a low of 9651.7% in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-5.22%
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	12.86%
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	46.39%
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	16.78%
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-2.77%
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-429.96%
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	13.24%
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	32.62%
10	CordovaCann	-	-	-	-

Download Data